2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow NFL Biosciences SAS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO) NFL-101, Placebo - Smoking Cessation, Nicotine Dependence | Phase 2 | Completed | NFL Biosciences SAS | 34 | 2023-02-21 | 2023-10-19 |
| Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy NFL-101 dose 1, NFL-101 dose 2, Placebo - Smoking Cessation, Nicotine Dependence | Phase 2 | Completed | NFL Biosciences SAS | 318 | 2021-04-12 | 2025-06-19 |
Smoking Cessation (2) · Tobacco Use Disorder (2)
Tobacco Products (2) · Injections (1) · Water (1)
France (2)